Sort
261,768 grants matching “gene therapy”
SPORE in Ovarian Cancer
$2,304,828Ie-Ming Shih · Johns Hopkins University · P50 · FY2021 · CA
SPORE in Ovarian Cancer
$2,304,828Ie-Ming Shih · Johns Hopkins University · P50 · FY2019 · CA
Systems Epigenomics of Persistent Bloodstream Infection
$2,304,639Michael R Yeaman · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U19 · FY2023 · AI
Structural Biology of Genome Maintenance and DNA repair
$2,303,975Robert Williams · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$2,303,568Rachel R. Caspi · National Eye Institute · ZIA · FY2015 · EY
Michigan Prostate SPORE 2025-2030
$2,303,511Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2025 · CA
MGH/MIT MORRIS UDALL CENTER OF EXCELLENCE IN PD RESEARCH
$2,303,361Massachusetts General Hospital · P50 · FY2005 · NS
Pathobiology of Cardiac Dyssynchrony & Resynchronization
$2,303,149David Alan Kass · Johns Hopkins University · P01 · FY2008 · HL
MEMORIAL SLOAN-KETTERING CANCER GENE THERAPY PROGRAM
$2,303,010Sloan-Kettering Institute For Cancer Res · P01 · FY2001 · CA
Characterization of the Fetal Primate Epigenome and Metabolome Under In Utero
$2,302,500Kjersti Marie Aagaard-Tillery · Baylor College Of Medicine · DP2 · FY2007 · OD
Stem cell, tumor and bone marrow microenvironment cross-talk in vivo
$2,302,500Dorothy A Sipkins · University Of Chicago · DP2 · FY2007 · OD
Transformed Probiotic Bacteria for Treatment of Chronic Diseases
$2,302,500Sean Stephen Davies · Vanderbilt University · DP2 · FY2007 · OD
Drugging the Undruggable: Targeting Transcription Factors with Small Cyclic Pept
$2,302,500Joshua A Kritzer · Tufts University Medford · DP2 · FY2010 · OD
New approaches to identify molecular mechanisms of touch and pain in mammals
$2,302,500Diana Michele Bautista · University Of California Berkeley · DP2 · FY2010 · OD
Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
$2,302,230Kornelia Polyak · Dana-Farber Cancer Inst · P50 · FY2023 · CA
Complete Human Peptide- and MRM-Atlas
$2,301,879Robert L Moritz · Institute For Systems Biology · RC2 · FY2010 · HG
Defining regulators of immunity to acute infection using CRISPR screens
$2,300,958Arlene H Sharpe · Harvard Medical School · U19 · FY2020 · AI
Developmental and Hyperactive Ras Tumor (DHART) SPORE
$2,300,532David W. Clapp · Indiana University Indianapolis · U54 · FY2025 · CA
Connecting the selection of noisy gene expression deviants to genetic evolution
$2,300,475Gabor Balazsi · University Of Tx Md Anderson Can Ctr · DP2 · FY2009 · OD
SPORE in Lung Cancer
$2,300,000Stephen B Baylin · Johns Hopkins University · P50 · FY2009 · CA
SPORE in Soft Tissue Sarcoma
$2,300,000Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2012 · CA
University of Texas SPORE in Lung Cancer
$2,300,000John D Minna · Ut Southwestern Medical Center · P50 · FY2009 · CA
FCCC-PENN SPORE in Ovarian Cancer
$2,300,000Michael V. Seiden · Fox Chase Cancer Center · P50 · FY2009 · CA
SPORE in GI Cancer
$2,300,000Robert J Coffey · Vanderbilt University · P50 · FY2012 · CA
RPCI-UPCI Ovarian Cancer SPORE
$2,300,000Kunle O Odunsi · Roswell Park Cancer Institute Corp · P50 · FY2017 · CA